Clinical trial

Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using…

NCT00279916 · Mayo Clinic, Other · Completed

Key facts

NCT number NCT00279916
Title Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
Official title Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays: a Randomized Placebo-controlled Study
Lead sponsor Mayo Clinic, Other
Collaborators Aventis Pharmaceuticals Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Otitis Media, Serous, Negative Middle Ear Pressure, Rhinitis, Otitis Media With Effusion, Secretory
Intervention type Drug
Interventions Triamcinolone acetonide nasal spray, Placebo nasal spray
Enrollment 91
Start date Sep 1, 2005
Primary completion Feb 1, 2009
Completion Mar 1, 2009
First posted Jan 20, 2006
Last update posted May 30, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies